HEATHER MEDNANSKY: Open Payments
NPI 1336664184 · SUN CITY, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$539 in 20 payments from 12 companies in 2025. Trend: 2023 $510 · 2024 $495 · 2025 $539
Food & beverage: $539
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 1 | $148 |
| PFIZER INC. | 5 | $103 |
| Abbott Laboratories | 3 | $70 |
| ABBVIE INC. | 2 | $50 |
| Cleerly, Inc. | 2 | $50 |
| Boston Scientific Corporation | 1 | $24 |
| Novo Nordisk Inc | 1 | $23 |
| Teleflex LLC | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
Products named: AIRSUPRA, ELIQUIS, Cleerly Ischemia, PROCLAIM, UBRELVY, JOT DX, General - Therapies, Rybelsus.
Industry payments across AZ — which companies pay providers there.
